Experts give their concluding thoughts on cardiovascular care and closing disparity gaps to optimize patient outcomes.
Positive 5-Year Results for Gefitinib Combo in EGFR-Variant Lung Cancer
Consistent with previous observations, overall survival and progression-free survival remained strong at the follow-up point.
Read More
Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong
Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.
Listen
Blood-Based CRC Screening Should Be Used Solely as Secondary Option
Blood-based screening for colorectal cancer (CRC) should only be used with patients who are not completing other endorsed screening options, according to a study.
Managed Care Cast Presents: Insights Into Precision Medicine in NSCLC
In this podcast, a trio of experts discuss precision medicine in non–small cell lung cancer (NSCLC), current immunotherapies, and more.
Novel Blood Biomarkers Show Potential for Early Liver Cancer Diagnosis
A predictive model using plasma proteins as biomarkers predicted hepatocellular carcinoma development more accurately than a model based on traditional lifestyle risk factors in a recent study.
Much-Improved Outcomes for Follicular Lymphoma Transformed to DLBCL in the Rituximab Era, Study Finds
Although histological transformation to diffuse large B-cell lymphoma (DLBCL) remains a common complication of follicular lymphoma, patient survival has increased significantly since the introduction of rituximab about 2 decades ago.